Interim (18F)FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [18F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2021, Jahrgang: 48, Heft: 6, Pages: 1932-1943 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-020-05137-7 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-020-05137-7 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00259-020-05137-7 
|
| Verfasserangaben: | Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss |
| Zusammenfassung: | In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [18F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. |
|---|---|
| Beschreibung: | Published online: 18 December 2020 Im Titel steht der Ausdruck (18 F) in eckiger Klammer, "18" ist dabei hochgestellt Gesehen am 11.01.2024 |
| Beschreibung: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-020-05137-7 |